<h1>Genomic research partnership advances rare disease diagnostics and therapeutics through biobank data and joint governance.</h1> The strategic alliance combines AGENOME's Biobank and sequence data with TIGS functional genomics expertise to discover actionable genetic markers, develop population-scale diagnostics and screening assays (including CRISPR approaches), evaluate mRNA therapeutics and in vivo gene therapy potential, and profile pharmacogenomic markers for precision medicine. Governance is vested in a co-chaired Joint Steering Committee to oversee research priorities, data use, ethical safeguards and commercialization strategies, with a stated commitment to accessibility of resulting knowledge and interventions for affected communities and broader populations.